Prenatal Intravenous Iron and Child Growth: A Secondary Analysis of a Randomized Clinical Trial.

ABSTRACT:

Importance

Maternal anemia during pregnancy is associated with poor growth during early childhood, but it remains unclear whether treatment using intravenous iron could enhance child growth.

Objective

To evaluate whether intravenous ferric carboxymaltose (FCM) treatment for moderate to severe anemia during the second trimester of pregnancy enhances postnatal child growth compared with standard-of-care (SOC) oral iron.

Design, setting, and participants

This was a prespecified secondary analysis of a randomized clinical trial (Randomized Controlled Trial of the Effect of Intravenous Iron on Anaemia in Malawian Pregnant Women [REVAMP]). In REVAMP, pregnant women with capillary hemoglobin between 5 and 10 g/dL were recruited in the Blantyre and Zomba districts of southern

SUBMITTER: Mzembe G 

PROVIDER: S-EPMC12569709 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature